Kathy L. Goetz
Independent DirectorMs. Kathy L. Goetz is Independent Director of Aurinia Pharmaceuticals Inc. from May 15, 2025. She is Trustee of Tekla Capital Management LLC from December 09, 2021. She joined the Tekla Capital Management LLC on December 09, 2021. She has previous experience at Novartis Pharmaceuticals: Vice President and Head of Sales (2017-2019), Executive Director of Strategic Account Management (2015-2016), Regional Sales Director - Neuroscience Business Unit (2012-2015), Marketing Brand Director - Reclast (2011), Ad Interim General Manager (2010), Managing Sales Director (2008-2010) and Integrated Markets, Strategic Planning (2007-2008). Ms. Goetz served as VP and Head of Sales, where she led the U.S. Neuroscience Franchise commercial sales organization. Ms. Goetz graduated from Iowa State University with a degree in Business Administration and Finance.
Positions
- Company NameAurinia Pharmaceuticals Inc.Stock CodeAUPHPositionIndependent DirectorColleagues
- KCKevin C. TangChairman & CEO
- SPStephen P. RobertsonChief Legal Officer, Corporate Secretary & Chief Compliance Officer
- PSPeter S. GreenleafConsultant
- MSMichael S. HearneChief Financial Officer
- RCRyan ColeChief Operating Officer
- JAJeffrey Allen BaileyIndependent Director
- CACraig A. JohnsonLead Independent Director
- TSTina S. NovaIndependent Director
